Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Scaling Challenges in Cell Therapy: Industry's Crucial Hurdle
Research & Development Scaling Challenges in Cell Therapy: Industry's Crucial Hurdle

Cell and gene therapies represent groundbreaking advances in the medical field, offering hope for cures to diseases once deemed incurable. The path to market for these innovative treatments, however, is fraught with complex challenges that test the resolve and creativity of biotech companies. They

Digital Health in Oncology: Transforming Cancer Care and Outcomes
Research & Development Digital Health in Oncology: Transforming Cancer Care and Outcomes

The integration of digital health into the field of oncology marks a pivotal shift in how cancer is managed and treated. This confluence of technology and healthcare has birthed new potentials in enhancing cancer prevention, diagnosis, treatment, and follow-up care. Digital health applications,

PeriCord Trial Shows Promise for Heart Repair Post-Attack
Biotech & Bioprocessing PeriCord Trial Shows Promise for Heart Repair Post-Attack

In a groundbreaking clinical trial, an innovative cardiac bioimplant named PeriCord has shown signs of fostering heart tissue repair following a myocardial infarction. Developed by the ICREC at the Germans Trias i Pujol Research Institute and the Banc de Sang i Teixits in Barcelona, Spain, PeriCord

Exploring National Digital Health Strategies in Europe
Tech & Innovation Exploring National Digital Health Strategies in Europe

The WHO's latest report offers an in-depth look at how European countries are incorporating digital technologies into their healthcare systems. With data from April to October 2022, the report titled "Exploring the digital health landscape in the WHO European Region: digital health country

Advancing Gene Therapy with High-Performance CASwitch Circuit
Biotech & Bioprocessing Advancing Gene Therapy with High-Performance CASwitch Circuit

Synthetic biology stands at the forefront of modern science, with gene therapy being one of its most exciting horizons. The ability to control gene expression within mammalian cells holds enormous potential for treating a myriad of diseases. However, achieving precise and robust inducible gene

How is the Bioinformatics Platforms Market Poised for Growth by 2031?
Tech & Innovation How is the Bioinformatics Platforms Market Poised for Growth by 2031?

In the undeniably complex field of bioinformatics, platforms that dissect and decipher genetic coding, propel drug development, and pave the way for personalized medicine are taking center stage. Coherent Market Insights, with their finger on the pulse of scientific innovation, presents a nuanced

How Will AI Revolutionize Precision Medicine and Care?
Tech & Innovation How Will AI Revolutionize Precision Medicine and Care?

The intersection of precision medicine and artificial intelligence (AI) is ushering in a transformative era, one where healthcare is redefined in its approach and interaction with patients. In a recent inspiring presentation, Dr. Eric Topol shared his insights into a not-so-distant future where AI

Australian Senate Questions AI Role in Immigration, Biosecurity
Biotech & Bioprocessing Australian Senate Questions AI Role in Immigration, Biosecurity

Rising Reliance on AI Decision-Making In a turn of events bringing the complexity of artificial intelligence (AI) to the political forefront, the Australian Senate is critically examining the growing utilization of AI in governmental decision-making processes, particularly within the immigration

Synthetic Biology Market Set to Surge to $52.6B by 2030
Biotech & Bioprocessing Synthetic Biology Market Set to Surge to $52.6B by 2030

Certainly! Here is the content formatted with the appropriate heading designations: The synthetic biology sector is on a trajectory to monumental expansion, expected to reach a valuation of $52.6 billion by 2030. This interdisciplinary field combines biology, engineering, computer science, and

Biotech Stocks Surge: Top 5 Performers Lead Industry Revival
Management & Regulatory Biotech Stocks Surge: Top 5 Performers Lead Industry Revival

After facing a slump during the COVID-19 pandemic, the biotech sector has made a remarkable recovery in early 2024. Economic disturbances and changes in healthcare focus had previously dampened the industry's growth. However, a spate of medical innovations and successful clinical trial data has now

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later